News & Events
FutuRx Launches GliXogen Therapeutics to Develop Novel Therapies for Multiple Sclerosis and Other Demyelinating DisordersPRWEB, January 14, 2019
The two startups are XoNovo (Alzheimer’s Disease) and Hepy Biosciences (cancer).
New biotech incubator to advance biotechnology products in Israel
FutuRx, a biotechnology incubator in Weizmann Science Park, is pleased to announce that its first two biotechnology companies have started operations. The companies are developing new approaches and candidate drugs in oncology and neurodegenerative disease.